{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:15:04Z","timestamp":1791216904060,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T00:00:00Z","timestamp":1216080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/sj.bjc.6604489","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T20:52:46Z","timestamp":1216155166000},"page":"536-538","source":"Crossref","is-referenced-by-count":11,"title":["Modification of second cancer risk after malignant melanoma by parental history of cancer"],"prefix":"10.1038","volume":"99","author":[{"given":"H","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Lorenzo","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,15]]},"reference":[{"key":"BF6604489_CR1","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2014::AID-CNCR19>3.0.CO;2-4","volume":"86","author":"S Bhatia","year":"1999","unstructured":"Bhatia S, Estrada-Batres L, Maryon T, Bogue M, Chu D (1999) Second primary tumors in patients with cutaneous malignant melanoma. Cancer 86: 2014\u20132020","journal-title":"Cancer"},{"key":"BF6604489_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1523-1747.2001.01224.x","volume":"116","author":"NF Box","year":"2001","unstructured":"Box NF, Duffy DL, Irving RE, Russell A, Chen W, Griffyths LR, Parsons PG, Green AC, Sturm RA (2001) Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol 116: 224\u2013229","journal-title":"J Invest Dermatol"},{"key":"BF6604489_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.0022-202X.2004.22501.x","volume":"122","author":"VL Brown","year":"2004","unstructured":"Brown VL, Harwood CV, Crook T, Cronin JG, Kelsell DR, Proby CM (2004) p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 122: 1284\u20131292","journal-title":"J Invest Dermatol"},{"key":"BF6604489_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10549-006-9382-x","volume":"103","author":"T Debniak","year":"2007","unstructured":"Debniak T, Cybulski C, G\u00f3rski B, Huzarski T, Byrski T, Gronwald J, Jakubowska A, Kowalska E, Oszurek O, Narod SA, Lubi\u0144ski J (2007) CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Res Treat 103: 355\u2013359","journal-title":"Breast Cancer Res Treat"},{"key":"BF6604489_CR5","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/j.ejca.2004.06.003","volume":"40","author":"E de Vries","year":"2004","unstructured":"de Vries E, Coebergh JW (2004) Cutaneous malignant melanoma in Europe. Eur J Cancer 40: 2355\u20132366","journal-title":"Eur J Cancer"},{"key":"BF6604489_CR6","first-page":"1077","volume":"67","author":"P Ebbesen","year":"1981","unstructured":"Ebbesen P (1981) Enhanced lymphoma incidence in BALB\/c mice after ultraviolet treatment. J Natl Cancer Inst 67: 1077\u20131078","journal-title":"J Natl Cancer Inst"},{"key":"BF6604489_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/archderm.143.4.495","volume":"143","author":"A Figl","year":"2007","unstructured":"Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D (2007) Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants. Arch Dermatol 143: 495\u2013499","journal-title":"Arch Dermatol"},{"key":"BF6604489_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/cncr.11116","volume":"97","author":"WB Goggins","year":"2003","unstructured":"Goggins WB, Tsao H (2003) A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma Survivors. Cancer 97: 639\u2013643","journal-title":"Cancer"},{"key":"BF6604489_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0140-6736(05)63267-9","volume":"350","author":"K Hemminki","year":"1997","unstructured":"Hemminki K, Vaittinen P (1997) Interaction of breast cancer and melanoma genotypes. Lancet 350: 931\u2013932","journal-title":"Lancet"},{"key":"BF6604489_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/archderm.136.5.647","volume":"136","author":"K Hemminki","year":"2000","unstructured":"Hemminki K, Dong C (2000) Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 136: 647\u2013651","journal-title":"Arch Dermatol"},{"key":"BF6604489_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0959-8049(02)00595-6","volume":"39","author":"K Hemminki","year":"2003","unstructured":"Hemminki K, Jiang Y, Steineck G (2003) Skin cancer and non-Hodgkin's lymphoma as second malignancies, markers of impaired immune function? Eur J Cancer 39: 223\u2013229","journal-title":"Eur J Cancer"},{"key":"BF6604489_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1897-4287-4-4-186","volume":"4","author":"K Hemminki","year":"2006","unstructured":"Hemminki K, Granstr\u00f6m C, Sundquist J, Lorenzo Bermejo J (2006) The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence. Heredit Cancer in Clin Pract 4: 186\u2013192","journal-title":"Heredit Cancer in Clin Pract"},{"key":"BF6604489_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller AJ, Mihm Jr MC (2006) Melanoma. N Engl J Med 355: 51\u201365","journal-title":"N Engl J Med"},{"key":"BF6604489_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/302711","volume":"66","author":"JS Palmer","year":"2000","unstructured":"Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66: 176\u2013186","journal-title":"Am J Hum Genet"},{"key":"BF6604489_CR15","first-page":"4007","volume":"48","author":"CA Romedahl","year":"1988","unstructured":"Romedahl CA, Donawho C, Fidler IJ, Kripke ML (1988) Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells. Cancer Res 48: 4007\u20134010","journal-title":"Cancer Res"},{"key":"BF6604489_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1046\/j.1365-2133.2001.04507.x","volume":"145","author":"M-H Schmid-Wendtner","year":"2001","unstructured":"Schmid-Wendtner M-H, Baumert J, Wendtner C-M, Plewig G, Volkenandt M (2001) Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 145: 981\u2013985","journal-title":"Br J Dermatol"},{"issue":"4","key":"BF6604489_CR17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1245\/s10434-007-9790-0","volume":"15","author":"S Sinha","year":"2008","unstructured":"Sinha S, Chunder N, Mukherjee N, Alam N, Roy A, Roychoudhury S, Kumar Panda C (2008) Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol 15 (4): 1070\u20131080","journal-title":"Ann Surg Oncol"},{"key":"BF6604489_CR18","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1038\/sj.onc.1202915","volume":"18","author":"N Soufir","year":"1999","unstructured":"Soufir N, Mol\u00e8s JP, Vilmer C, Moch C, Verola O, Rivet J, Tesniere A, Dubertret L, Basset-Seguin N (1999) P16 UV mutations in human skin epithelial tumors. Oncogene 18: 5477\u20135481","journal-title":"Oncogene"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604489","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:34:14Z","timestamp":1684413254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,15]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BF6604489"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604489","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,15]]}}}